SpecsAI

SpecsAI is designed to automate the development of pharmaceutical specifications for WHO. It transforms a traditionally manual and time-intensive process into a scalable, intelligent workflow that analyses technical data, generates pharmacopoeial specifications, and validates outputs against established standards with human oversight.  (This is a specialised tool intended for restricted use only.)

Purpose

• Automate the creation of pharmaceutical specifications (monographs)
• Reduce processing time and address backlog in specification development
• Ensure alignment with WHO, ICH, and pharmacopoeial standards
• Support consistent, traceable, and high-quality outputs

The tool addresses the current constraints of manual processing, where specification development can take weeks per product. 

Target users

• WHO technical experts in pharmaceutical standards and specifications

Key features

• AI-driven specification generation: Produces structured pharmacopoeial specifications from multiple data sources
• Data analysis & synthesis: Processes complex technical documents (e.g. manufacturer data, scientific literature)
• Pharmacopoeia validation: Cross-references outputs with existing pharmacopoeia to ensure consistency and prevent duplication
• Standards integration: Applies WHO, ICH, and pharmacopoeial guidelines automatically
• Quality and compliance checks: Validates terminology, structure, units, and references against standards
• Human-in-the-loop review: Ensures all AI-generated outputs are reviewed and validated by experts
• Traceability and auditability: Maintains source attribution and justification for generated outputs

Typical use cases

• Developing pharmacopoeial specifications for medicines
• Processing and analysing manufacturer submissions (CMC data)
• Drafting and validating monographs for WHO prequalification
• Supporting normative product development workflows
• Reducing backlog in pharmaceutical specification development

Impact statement

SpecsAI helps to reduce specification development timelines from weeks to days, improving consistency and quality, and enabling the Organization to address large backlogs of pharmaceutical specifications. By combining AI-driven analysis with expert validation, it strengthens WHO’s ability to deliver high-quality standards at scale while ensuring accuracy, traceability, and compliance. 

Other tags / keywords

• Pharmacopoeia; Pharmaceutical Standards; Normative Products; Pharmaceutical Specification Development

Business sponsor

• Luther Gwaza